Literature DB >> 19721445

Protein methyltransferases as a target class for drug discovery.

Robert A Copeland1, Michael E Solomon, Victoria M Richon.   

Abstract

The protein methyltransferases (PMTs) - which methylate protein lysine and arginine residues and have crucial roles in gene transcription - are emerging as an important group of enzymes that play key parts in normal physiology and human diseases. The collection of human PMTs is a large and diverse group of enzymes that have a common mechanism of catalysis. Here, we review the biological, biochemical and structural data that together present PMTs as a novel, chemically tractable target class for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19721445     DOI: 10.1038/nrd2974

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  75 in total

1.  NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15).

Authors:  Roberto Rosati; Roberta La Starza; Angelo Veronese; Ana Aventin; Christine Schwienbacher; Teresa Vallespi; Massimo Negrini; Massimo F Martelli; Cristina Mecucci
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

Review 2.  Unsafe SETs: histone lysine methyltransferases and cancer.

Authors:  Robert Schneider; Andrew J Bannister; Tony Kouzarides
Journal:  Trends Biochem Sci       Date:  2002-08       Impact factor: 13.807

3.  Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1.

Authors:  Jing Huang; Jennifer R Kent; Brandon Placek; Kelly A Whelan; Charles M Hollow; Ping-Yao Zeng; Nigel W Fraser; Shelley L Berger
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines.

Authors:  P O Angrand; F Apiou; A F Stewart; B Dutrillaux; R Losson; P Chambon
Journal:  Genomics       Date:  2001-05-15       Impact factor: 5.736

5.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.

Authors:  Quan Zhao; Gerhard Rank; Yuen T Tan; Haitao Li; Robert L Moritz; Richard J Simpson; Loretta Cerruti; David J Curtis; Dinshaw J Patel; C David Allis; John M Cunningham; Stephen M Jane
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

6.  Substrate specificity and kinetic mechanism of mammalian G9a histone H3 methyltransferase.

Authors:  Debasis Patnaik; Hang Gyeong Chin; Pierre-Olivier Estève; Jack Benner; Steven E Jacobsen; Sriharsa Pradhan
Journal:  J Biol Chem       Date:  2004-10-14       Impact factor: 5.157

7.  The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.

Authors:  Jotin Marango; Manabu Shimoyama; Hitomi Nishio; Julia A Meyer; Dong-Joon Min; Andres Sirulnik; Yolanda Martinez-Martinez; Marta Chesi; P Leif Bergsagel; Ming-Ming Zhou; Samuel Waxman; Boris A Leibovitch; Martin J Walsh; Jonathan D Licht
Journal:  Blood       Date:  2007-12-21       Impact factor: 22.113

8.  Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity.

Authors:  Ji-Young Kim; Hae Jin Kee; Nak-Won Choe; Sung-Mi Kim; Gwang-Hyeon Eom; Hee Jo Baek; Hyun Kook; Hoon Kook; Sang-Beom Seo
Journal:  Mol Cell Biol       Date:  2008-01-02       Impact factor: 4.272

9.  NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.

Authors:  Gang G Wang; Ling Cai; Martina P Pasillas; Mark P Kamps
Journal:  Nat Cell Biol       Date:  2007-06-24       Impact factor: 28.824

10.  Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294.

Authors:  Yanqi Chang; Xing Zhang; John R Horton; Anup K Upadhyay; Astrid Spannhoff; Jin Liu; James P Snyder; Mark T Bedford; Xiaodong Cheng
Journal:  Nat Struct Mol Biol       Date:  2009-02-15       Impact factor: 15.369

View more
  174 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

2.  A complex Polycomb issue: the two faces of EZH2 in cancer.

Authors:  Hanno Hock
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

3.  Kinetics of re-establishing H3K79 methylation marks in global human chromatin.

Authors:  Steve M M Sweet; Mingxi Li; Paul M Thomas; Kenneth R Durbin; Neil L Kelleher
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

4.  Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases.

Authors:  Yanqi Chang; Thota Ganesh; John R Horton; Astrid Spannhoff; Jin Liu; Aiming Sun; Xing Zhang; Mark T Bedford; Yoichi Shinkai; James P Snyder; Xiaodong Cheng
Journal:  J Mol Biol       Date:  2010-04-29       Impact factor: 5.469

5.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.

Authors:  Christopher J Sneeringer; Margaret Porter Scott; Kevin W Kuntz; Sarah K Knutson; Roy M Pollock; Victoria M Richon; Robert A Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

6.  Development and validation of a generic fluorescent methyltransferase activity assay based on the transcreener AMP/GMP assay.

Authors:  Tony A Klink; Matt Staeben; Kim Twesten; Andrew L Kopp; Meera Kumar; Rebecca Schall Dunn; Cori A Pinchard; Karen M Kleman-Leyer; Martin Klumpp; Robert G Lowery
Journal:  J Biomol Screen       Date:  2011-09-28

7.  Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1.

Authors:  Sabrina Castellano; Astrid Spannhoff; Ciro Milite; Fabrizio Dal Piaz; Donghang Cheng; Alessandra Tosco; Monica Viviano; Abdellah Yamani; Agostino Cianciulli; Marina Sala; Vincent Cura; Jean Cavarelli; Ettore Novellino; Antonello Mai; Mark T Bedford; Gianluca Sbardella
Journal:  J Med Chem       Date:  2012-11-02       Impact factor: 7.446

8.  CARMA: CARM1 methylation of SWI/SNF in breast cancer.

Authors:  Xiaofeng Wang; Charles W M Roberts
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

9.  Pharmacophore-based screening of diamidine small molecule inhibitors for protein arginine methyltransferases.

Authors:  Kun Qian; Chunli Yan; Hairui Su; Tran Dang; Bo Zhou; Zhenyu Wang; Xinyang Zhao; Ivaylo Ivanov; Meng-Chiao Ho; Y George Zheng
Journal:  RSC Med Chem       Date:  2020-09-30

10.  Design, synthesis, and protein methyltransferase activity of a unique set of constrained amine containing compounds.

Authors:  Hao Zhou; Xin Che; Guochen Bao; Na Wang; Li Peng; Kimberly D Barnash; Stephen V Frye; Lindsey I James; Xu Bai
Journal:  Bioorg Med Chem Lett       Date:  2016-08-03       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.